Pharmacological Treatment of Insomnia Symptoms in Individuals with Substance Use Disorders in Spain: A Quasi-Experimental Study-Reference-Cited by-同舟云学术

Pharmacological Treatment of Insomnia Symptoms in Individuals with Substance Use Disorders in Spain: A Quasi-Experimental Study

Published:2017-11-29 Issue:8 Volume:53 Page:1267-1274
ISSN:1082-6084
Container-title:Substance Use & Misuse
language:en
Short-container-title:Substance Use & Misuse

Author:

Grau-López L.¹²,Grau-López L.³,Daigre C.¹²,Palma-Álvarez R. F.¹^ORCID,Rodriguez–Cintas L.¹²,Ros-Cucurull E.¹²,Roncero C.¹²^ORCID

Affiliation:

1. Addiction and Dual Diagnosis Unit, Department of Psychiatry, Vall d'Hebron University Hospital-Public Health Agency, Barcelona (ASPB), CIBERSAM, Barcelona, Spain

2. Department of Psychiatry and Legal Medicine, Universidad Autónoma de Barcelona, Barcelona, Spain

3. Department of Neurosciences, Germans Tries i Pujol Hospital, Badalona, Barcelona, Spain

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Medicine (miscellaneous),Health (social science)

Link

https://www.tandfonline.com/doi/pdf/10.1080/10826084.2017.1402056

Reference37 articles.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Study of the Effect of Melatonin and Zolpidem on Sleep Quality and General Health of Patients on Methadone Maintenance Treatment;SSRN Electronic Journal;2022

2. Circadian Characteristics in Patients under Treatment for Substance Use Disorders and Severe Mental Illness (Schizophrenia, Major Depression and Bipolar Disorder);Journal of Clinical Medicine;2021-09-25

3. Insomnia Symptoms in Patients With Substance Use Disorders During Detoxification and Associated Clinical Features;Frontiers in Psychiatry;2020-11-17

4. The Relevance of Dual Diagnoses among Drug-Dependent Patients with Sleep Disorders;Journal of Clinical Medicine;2020-09-04

5. Assessment of Subjective Sleep Problems in Men With Opioid Dependence Maintained on Buprenorphine;Journal of Addiction Medicine;2020-03